Cargando…

Clinical Outcomes of Ductal Carcinoma In Situ of the Breast Treated with Partial Mastectomy without Adjuvant Radiotherapy

PURPOSE: Some recent trials suggest that postoperative adjuvant radiotherapy (RT) may be safely omitted after breast-conserving surgery (BCS) for some patients with ductal carcinoma in situ (DCIS). In this study, we reviewed clinical outcomes of patients with DCIS treated with partial mastectomy (PM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Seung Hyun, Jeong, Joon, Ahn, Sung Gwe, Lee, Hak Min, Lee, Hy-De
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343427/ https://www.ncbi.nlm.nih.gov/pubmed/22476997 http://dx.doi.org/10.3349/ymj.2012.53.3.537

Ejemplares similares

Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
por: Giannakeas, Vasily, et al.
Publicado: (2018)

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience
por: Cutuli, B, et al.
Publicado: (2009)

Long-Term Survival Analysis of Korean Breast Cancer Patients at a Single Center: Improving Outcome Over Time
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Prospective Evaluation of the Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Negative Axillary Conversion after Neoadjuvant Chemotherapy
por: Lee, Hy-De, et al.
Publicado: (2015)

Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy
por: GÜZELÖZ, Zeliha, et al.
Publicado: (2019)

Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy
por: Chien, Ju-Chun, et al.
Publicado: (2022)

Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
por: Lee, Janghee, et al.
Publicado: (2021)

The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion
por: Xia, Lin-Yu, et al.
Publicado: (2022)

Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
por: Kim, Taeryung, et al.
Publicado: (2014)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients
por: Kim, Hyung Won, et al.
Publicado: (2014)

Comparison of complications according to incision types in nipple-sparing mastectomy and immediate reconstruction
por: Park, Soeun, et al.
Publicado: (2020)

Metastases after mastectomy for ductal carcinoma in situ of the male breast; A case report
por: Pant, Ved Prakash, et al.
Publicado: (2022)

Nipple-sparing Mastectomy with Immediate Implant-based Reconstruction for Patients with Pure Ductal Carcinoma in Situ
por: Frasson, Antônio Luiz, et al.
Publicado: (2022)

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
por: van Seijen, Maartje, et al.
Publicado: (2021)

Comparison of Outcomes between Direct-to-Implant Breast Reconstruction Following Nipple-Sparing Mastectomy through Inframammary Fold Incision versus Noninframammary Fold Incision
por: Roh, Tai Suk, et al.
Publicado: (2018)

Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy
por: Pawloski, Kate R., et al.
Publicado: (2021)

Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
por: Yoon, Chang Ik, et al.
Publicado: (2023)

Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer
por: Lee, Seung Ah, et al.
Publicado: (2018)

Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ
por: Timbrell, Simon, et al.
Publicado: (2016)

In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost
por: Lee, Jason Joon Bock, et al.
Publicado: (2017)

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Adjuvant postmastectomy radiotherapy might be associated with better survival in women with heart failure receiving total mastectomy
por: Zhang, Jiaqiang, et al.
Publicado: (2022)

Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ
por: Riou, Olivier, et al.
Publicado: (2012)

Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse
por: Kim, Hee Jun, et al.
Publicado: (2015)

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay
por: Ahn, Sung Gwe, et al.
Publicado: (2017)

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

Multiple metastases of bones and sigmoid colon after mastectomy for ductal carcinoma in situ of the breast: a case report
por: You, Qiuting, et al.
Publicado: (2019)

Established and Validated Novel Nomogram for Predicting Prognosis of Post-Mastectomy pN0-1 Breast Cancer without Adjuvant Radiotherapy
por: Qi, Wei-Xiang, et al.
Publicado: (2021)

Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials
por: Viani, Gustavo A, et al.
Publicado: (2007)

Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy?
por: Lee, Jeonghui, et al.
Publicado: (2011)

Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
por: Yang, Seongwoo, et al.
Publicado: (2023)

Association of the 12-Gene Breast DCIS Score(®) Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols
por: Leonard, Charles E., et al.
Publicado: (2021)

Local Control of Brain Metastasis: Treatment Outcome of Focal Brain Treatments in Relation to Subtypes
por: Chong, Jae Uk, et al.
Publicado: (2015)

For Stage II Node-Positive Breast Cancer, is it Worthwhile to Consider Adjuvant Radiotherapy Following Mastectomy?
por: Osman, Mohammed A. M., et al.
Publicado: (2014)

Breast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy
por: Kinsey-Trotman, Stephen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dm2em11p7cb9sgad355r905s2m